Jerome Braudeau

4 Rue Pierre Fontaine
Evry, 91000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Corrigendum to "Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study" [The Journal of Prevention of Alzheimer's Disease 2024;11(3):567-581].

Corrigendum to "Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study" [The Journal of Prevention of Alzheimer's Disease 2024;11(3):567-581].

Journal: The journal of prevention of Alzheimer's disease

Published: January 25, 2025

Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.

Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.

Journal: The journal of prevention of Alzheimer's disease

Published: May 06, 2024

Biological Diagnosis of Alzheimer's Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?

Biological Diagnosis of Alzheimer's Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?

Journal: International journal of molecular sciences

Published: November 07, 2023

Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats.

Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats.

Journal: The journal of prevention of Alzheimer's disease

Published: July 16, 2022

Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia.

Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia.

Journal: The journal of prevention of Alzheimer's disease

Published: May 11, 2022

Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice.

Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice.

Journal: Acta neuropathologica communications

Published: January 04, 2019

Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain.

Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain.

Journal: Molecular therapy. Methods & clinical development

Published: December 25, 2018

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?

Journal: Neural regeneration research

Published: March 21, 2018

βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease.

βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease.

Journal: Cerebral cortex (New York, N.Y. : 1991)

Published: August 02, 2017

Transient increase in sAPPα secretion in response to Aβ1-42 oligomers: an attempt of neuronal self-defense?

Transient increase in sAPPα secretion in response to Aβ1-42 oligomers: an attempt of neuronal self-defense?

Journal: Neurobiology of aging

Published: March 06, 2017

Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.

Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.

Journal: Brain : a journal of neurology

Published: June 08, 2016

Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.

Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.

Journal: Molecular neurodegeneration

Published: October 26, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026